Dry Ice Replenishment Planning for mRNA Vaccine Shipment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The shipment of mRNA and mRNA vaccine materials requires precise temperature control below freezing, which is challenging due to ambient temperature variations and the need for constant re-evaluation of dry ice quantities during distribution, especially with multiple re-packaging events, posing risks of temperature excursions and regulatory compliance issues.
Innovation Solution
A programmed computer determines the initial amount of dry ice needed based on container configurations and predicted ambient conditions, with real-time monitoring and data analysis to adjust dry ice quantities at each depot, ensuring temperature maintenance and providing alerts for potential excursions, allowing for diversion to nearby sites for immediate administration if necessary.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If passive refrigeration systems with dry ice are used to maintain low temperatures during shipment, then the required storage temperature can be achieved, but the quantity of dry ice must be constantly re-evaluated and adjusted during re-packaging, increasing operational complexity
Solution Approach 1:
The system pre-calculates and determines the appropriate quantity of dry ice to be placed in containers before shipment based on predicted ambient conditions and shipment duration. This preliminary action eliminates the need for constant re-evaluation during re-packaging operations, while still achieving the required temperature maintenance through proactive planning and preparation.
2Stability of the object's composition
If the quantity of dry ice is increased to ensure sufficient cooling during extended shipment, then temperature stability is improved, but the sublimation rate increases and the effective shipment period is reduced
Solution Approach 1:
The system dynamically adjusts the quantity of dry ice based on actual ambient temperature conditions encountered during shipment. By continuously monitoring temperature and recalculating the optimal dry ice quantity, the system adapts to changing conditions - using more dry ice when temperatures are higher and less when conditions are favorable, thereby optimizing both temperature stability and extending the effective shipment period.
3Reliability
If real-time monitoring of temperature and dry ice quantity is implemented, then regulatory compliance and cargo safety are improved, but the system complexity and cost increase
Solution Approach 1:
The system implements real-time monitoring of temperature and dry ice quantity with automatic feedback loops that trigger alerts and notifications when thresholds are approached. This feedback mechanism provides continuous verification of shipping conditions for regulatory compliance while maintaining relatively simple system architecture through automated decision-making algorithms that reduce the need for complex manual monitoring procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution extends the effective life of mRNA vaccines by optimizing dry ice usage, ensuring regulatory compliance, and allowing for timely administration by predicting and managing temperature and humidity conditions throughout the shipment process.
Implementation Method 1
Sustained temperatures low enough even for Pfizer's COVID-19 mRNA vaccine can be achieved using dry ice in expanded polystyrene (EPS) container systems
Implementation Method 2
The ambient temperature significantly affects the sublimation rate of the dry ice
Implementation Method 3
Sustained temperatures low enough even for Pfizer's COVID-19 mRNA vaccine can be achieved using dry ice in expanded polystyrene (EPS) container systems
Data Source
AI summary
Disclosed is a method of maintaining an initial quantity of mRNA vaccine cargo in an EPS container containing dry ice as a passive coolant during shipment from a manufacturing site, wherein the initial quantity of mRNA vaccine cargo is shipped to a first depot and then repackaged into smaller quantities at one or more additional depots en route to the final destinations. Dry ice can be added or ordered in advance to be available at the next depot for the cargo. Indicators show the status of the cargo and whether it has undergone unacceptable temperature or humidity excursions.